Our biopharma manufacturing solutions support the development and production of life-changing treatments for patients around the world.
Today’s biologic drugs provide breakthrough treatment options for many of the world’s most challenging diseases and chronic conditions.
As a supplier for the largest biopharmaceutical manufacturers in the world, Avantor® is a trusted partner who provides the products, services, solutions, and expertise necessary to move through research and production quickly and confidently.
Avantor offers a unique combination of industry expertise and a broad portfolio of biopharma products and materials engineered and manufactured to satisfy the highest quality standards and regulatory requirements for your final product, whether it is a vaccine, monoclonal antibody, recombinant protein, cell therapy, gene therapy, or small molecule treatment.
Our biopharma products and services
Our quality systems are proven and audited by biopharma manufacturers and regulatory bodies worldwide. We emphasize quality in all our processes, starting with raw material procurement through cGMP manufacturing at multiple scales, handling, and distribution.
Biopharma manufacturing solutions
Primarily developed to target infectious diseases, new vaccine concepts focus on immune-oncology applications. Animal sera and buffer components are among the products we offer for vaccine manufacturing.
From a full range of cGMP production chemicals, excipients, and chromatography resins to single-use assemblies, our products address the need to maintain quality, activity, and stability throughout the entire mAbs scale-up and production.
Gene therapies offer the prospect of curative benefits to patients who have genetic or acquired diseases. From fermentation media to culture plasma DNA vectors and purification of CAR vectors used to engineer T-cells, our resources can help drive new cures.
Recombinant proteins are manufactured using microbial (E. coli) expression systems. Choose from our offering of cell culture supplements, chromatography resins, and a broad range of excipients for recombinant protein manufacturing.
Cell therapies offer new hope for patients in the fight against life-altering diseases, such as cancer. Our fill and finish excipients, cell culture media, and sera can be tailor packaged for the new cell therapy needs and are among the many products we offer for this developing bioprocessing application.
mRNA vaccines & therapies are produced via a simple and rapid, cell-free process. Explore our offering of in vitro transcription reagents, process chemicals and fluid handling solutions for mRNA therapeutic manufacturing.
Single-use products and systems provide increased flexibility and speed in biopharma manufacturing. Avantor is an open-architecture provider of innovative, single-use technology to support your bioprocessing workflows.
Buffers play a significant role in biopharmaceutical manufacturing. Avantor can help reduce the cost and time of buffer preparation with novel, alternative buffer management strategies that can be applied as stand-alone solutions or in combination to achieve workflow improvements, depending on the size of your operations and facility.
No matter how drugs or treatments are delivered, small molecule pharmaceutical manufacturers know they can formulate, manufacture, and innovate confidently using excipients and other products from Avantor.
Get started with Avantor
We make it easy to find the right biopharma products and solutions and are here to support you during every stage of your processes. Avantor can help you increase lab operation efficiency, reduce costs, and improve regulatory compliance. That means you and your team can focus on scientific innovation and discovery rather than spend time handling operational challenges.
As a supplier for the largest biopharma manufacturers in the world, Avantor® is a trusted partner that provides the products, services, solutions, and expertise needed to move through research and production quickly and confidently.
We help our customers reach the market faster and more safely with new treatments for patients from the bench to the pilot plant and through all required steps in complete commercial manufacturing.
To get started, complete this form. Our experienced team will contact you to discuss the biopharma solutions that are best for your production processes.
In producing monoclonal antibodies (mAbs), finding ways to remove bottlenecks and improve yields in downstream processing is a key focus area for biopharma manufacturers.